This video, led by Prof. Christian Marth, explores the latest treatment strategies for advanced/recurrent endometrial cancer. It highlights the shift from traditional chemotherapy to personalised therapies driven by molecular profiling.

The animated video walks you through a patient case study as you review:

  • The role of molecular subtypes in guiding treatment
  • Current 1st line options in patients with non-dMMR advanced/recurrent EC, including immunotherapy, PARP inhibitors, and targeted therapies
  • The importance of clear patient communication to support informed decision-making and optimise care

 

Clinical takeaways

  • Molecular classification is crucial not only for prognosis but also for guiding personalised treatment decisions 
  • ICI and ChT combination, including with maintenance olaparib, demonstrates PFS benefits and manageable safety in patients with non-dMMR advanced/recurrent endometrial cancer, with greater efficacy observed in dMMR populations 
  • Lenvatinib plus pembrolizumab is a viable option not only as 2nd line therapy but also as 1st line treatment for patients with non-dMMR advanced/recurrent endometrial cancer who have progressed after prior systemic therapy in any setting
  • Shared decision-making, supported by patient education, is essential for optimising treatment outcomes 
  • Understand current treatment options for advanced or recurrent endometrial cancer and their place in the treatment landscape
  • Explore treatment decisions in advanced or recurrent endometrial cancer based on molecular subtypes
  • Embrace the importance of clear communication with patients and agreement on the end goal of the treatment

Professor Christian Marth, MD, PhD

Christian Marth is since 1998 Head and Professor of the Department of Obstetrics and Gynecology at Innsbruck Medical University in Austria. He has been President of the AGO Austria, Chair of the Ovarian Committee of GCIG, Council member of the ESGO, President of the Austrian Association of Obstetrics and Gynecology, and Chair of the ENGOT. He is President of the AGO Austria Study Center, and Vice-President of the Austrian Breast and Colorectal Study Group. Christian Marth has been the author of more than 450 peer-reviewed articles, has received 13 national and international awards, and has an h-index of 86.

Prof. Christian Marth has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

EU, FWF, AstraZeneca, Roche, Novartis, MSD, Pharmamar, GSK, Pfizer, ImmunoGen, Daiichi Sankyo, BioNTech, Novocure, Eisai

Programme summary
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.
Endorsement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
OBSTETRICS & GYNECOLOGY CONNECT 

OBSTETRICS & GYNECOLOGY CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Eisai Europe Ltd, Aspivix and Novo Nordisk.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update
Oncology 
Highlights from ASCO 2025

Coming Soon: Expert insights on the latest data 

Experts
Prof. Mark Socinski, Dr Elizabeth Smyth, Dr Paolo Tarantino, Dr Domenica Lorusso, Prof. Gerhardt Attard
Endorsed by
Exon20group Biomarker Collaborative ICAN international cancer advocacy network
Lung Cancer Europe
  • clock 1 MIN
  • calendar May 2025

The oncogene-addicted NSCLC supported through an Independent Educational Grant from Bayer with all other updates supported by COR2ED
symposium Symposium
Oncology 
ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium

Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer

Experts
Prof. Wolfgang Janni, Prof. Sherko Kümmel, Prof. Michail Ignatiadis
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar May 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
podcast Podcast
Hemostasis and bleeding disorders Oncology 
Serie de podcasturi referitoare la gestionarea trombozei

Experți de renume din domeniul medical își împărtășesc perspectivele. Navigați în secțiuni pentru a selecta un episod al podcastului 

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis, Prof. Jerzy Windyga, Prof. Daniel Bolliger
  • download Downloadable
    Resources
  • clock 21 MIN
  • calendar May 2025

This educational programme is supported by an Independent Educational Grant from Viatris.
video Video
Oncology Hemato-oncology 
Optimising the sequence of novel therapies from early relapse in multiple myeloma

Improving the survival of patients with relapsed/refractory multiple myeloma

Experts
Prof. Hermann Einsele, Prof. Evangelos Terpos
  • download Downloadable
    Resources
  • clock 2 MIN
  • calendar May 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
animated-video Animated Video
Oncology 
BRAF V600E mutated NSCLC: The evolving treatment landscape

Expert insights into personalised treatment strategies in BRAF-mutated NSCLC

Experts
Prof. Amanda Tufman
Endorsed by
BRAF Bombers ICAN international cancer advocacy network Biomarker Collaborative
Lung Cancer Europe
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar May 2025

This content is intended for HCPs outside the UK & ROI only. The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. This programme is supported by an Independent Educational Grant from Pierre Fabre Laboratories.  The programme is, therefore, independent; the content is not influenced by Pierre Fabre Laboratories and is under the sole responsibility of the experts. 
podcast Podcast
Oncology 
Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC)

Chemotherapy strategies that matter

Experts
Prof. Shubham Pant, Prof. Efrat Dotan
Endorsed by
DiCE ICAN international cancer advocacy network
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar May 2025

Educational programme supported by an Independent Educational Grant from Ipsen USA